These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15917430)

  • 1. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.
    Wang LX; Ni J; Singh S; Li H
    Chem Biol; 2004 Jan; 11(1):127-34. PubMed ID: 15113002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study.
    Wang J; Li H; Zou G; Wang LX
    Org Biomol Chem; 2007 May; 5(10):1529-40. PubMed ID: 17571181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.
    Marradi M; Di Gianvincenzo P; Enríquez-Navas PM; Martínez-Ávila OM; Chiodo F; Yuste E; Angulo J; Penadés S
    J Mol Biol; 2011 Jul; 410(5):798-810. PubMed ID: 21440555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
    Enríquez-Navas PM; Marradi M; Padro D; Angulo J; Penadés S
    Chemistry; 2011 Feb; 17(5):1547-60. PubMed ID: 21268157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
    Pantophlet R; Wilson IA; Burton DR
    Protein Eng Des Sel; 2004 Oct; 17(10):749-58. PubMed ID: 15542540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
    Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
    Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessibility of the high-mannose glycans of glycoprotein gp120 from human immunodeficiency virus type 1 probed by in vitro interaction with mannose-binding lectins.
    Astoul CH; Peumans WJ; Van Damme EJ; Roug
    Biochem Biophys Res Commun; 2000 Aug; 274(2):455-60. PubMed ID: 10913359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes.
    Di Gianvincenzo P; Chiodo F; Marradi M; Penadés S
    Methods Enzymol; 2012; 509():21-40. PubMed ID: 22568899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.
    Balzarini J; Van Laethem K; Hatse S; Froeyen M; Van Damme E; Bolmstedt A; Peumans W; De Clercq E; Schols D
    Mol Pharmacol; 2005 May; 67(5):1556-65. PubMed ID: 15718224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12].
    Tumanova OIu; Kuvshinov VN; Il'ichev AA; Nekrasov BG; Ivanisenko VA; Kozlov AP; Sandakhchiev LS
    Mol Biol (Mosk); 2002; 36(4):657-63. PubMed ID: 12173470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy.
    Martines E; García I; Marradi M; Padro D; Penadés S
    Langmuir; 2012 Dec; 28(51):17726-32. PubMed ID: 23198686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
    Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
    J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency.
    Dudkin VY; Orlova M; Geng X; Mandal M; Olson WC; Danishefsky SJ
    J Am Chem Soc; 2004 Aug; 126(31):9560-2. PubMed ID: 15291558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
    Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
    J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
    Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
    Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.
    Sanders RW; Venturi M; Schiffner L; Kalyanaraman R; Katinger H; Lloyd KO; Kwong PD; Moore JP
    J Virol; 2002 Jul; 76(14):7293-305. PubMed ID: 12072528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.